Cipla associate Avenue Therapeutics fails to get FDA approval for IV tramadol
Cipla’s step-down associate firm Avenue Therapeutics has failed to get approval from the US Food and Drug Administration (FDA) for IV tramadol as an alternative ... Read More
US online retail company Boxed to go public in $900m SPAC deal
Boxed, Inc., an American e-commerce grocery shopping platform, has agreed to merge with Seven Oaks Acquisition Corp. in a deal that values the combined company ... Read More
RattanIndia backed Revolt to gain Rs 48k per bike under revised FAME II scheme
Revolt Intellicorp is said to gain INR 48,000 incentive per bike that it sells owing to the major revisions made by the Indian government to ... Read More
Lupin Limited gets FDA warning letter for Lupin Somerset site
Indian pharma company Lupin Limited said that it has been issued a warning letter from the US Food and Drug Administration (FDA) for its manufacturing ... Read More
Krispy Kreme Doughnuts launches limited edition Lemonade Glaze Collection
North Carolina-based doughnut company Krispy Kreme Doughnuts has rolled out the Lemonade Glaze Collection that includes “freshly squeezed” doughnuts at participating shops across the US. ... Read More
United Natural Foods rolls out Woodstock hot sauces line in US
United Natural Foods, a Rhode Island-based organic food company, has rolled out a new range of hot sauces under Woodstock brand. The Woodstock hot sauces ... Read More
SIGNA Sports United, WiggleCRC to merge with Yucaipa in $3.2bn deal
SIGNA Sports United (SSU), a German online sporting goods retailer, and UK-based online bike retailer WiggleCRC Group have agreed to merge with Yucaipa Acquisition Corporation, ... Read More
ImmVira wraps up first dosing for MVR-T3011 in US and China
ImmVira said that it has wrapped up the first dosing of its oncolytic virus product - MVR-T3011 intratumoral injection in phase 2 clinical trials both ... Read More
AbbVie’s ibrutinib, venetoclax combo succeeds in phase 3 GLOW study
AbbVie said that the phase 3 GLOW study in chronic lymphocytic leukemia (CLL) investigating the combination of IMBRUVICA (ibrutinib) plus VENCLEXTA/VENCLYXTO (venetoclax) (I+V) has met ... Read More
Organic infant formula company Bobbie secures $15m in Series A round
Bobbie, an American organic infant formula company, has raised $15 million in a Series A funding round led by VMG Partners. Founded in January 2021 ... Read More